Literature DB >> 11905808

Actin' up: RhoB in cancer and apoptosis.

G C Prendergast1.   

Abstract

RhoB is a small GTPase that regulates actin organization and vesicle transport. It is required for signalling apoptosis in transformed cells that are exposed to farnesyltransferase inhibitors, DNA-damaging agents or taxol. Genetic analysis in mice indicates that RhoB is dispensable for normal cell physiology, but that it has a suppressor or negative modifier function in stress-associated processes, including cancer.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11905808     DOI: 10.1038/35101096

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   60.716


  69 in total

Review 1.  Cranial neural crest cells on the move: their roles in craniofacial development.

Authors:  Dwight R Cordero; Samantha Brugmann; Yvonne Chu; Ruchi Bajpai; Maryam Jame; Jill A Helms
Journal:  Am J Med Genet A       Date:  2010-12-10       Impact factor: 2.802

2.  RhoB controls Akt trafficking and stage-specific survival of endothelial cells during vascular development.

Authors:  Irit Adini; Isaac Rabinovitz; Jing Fang Sun; George C Prendergast; Laura E Benjamin
Journal:  Genes Dev       Date:  2003-11-01       Impact factor: 11.361

3.  NSC126188, a piperazine alkyl derivative, induces apoptosis via upregulation of RhoB in HeLa cells.

Authors:  Bo-Kyung Kim; Dong-Myung Kim; Kyung-Sook Chung; Song-Kyu Park; Shin-Jung Choi; Alexander Song; Kiho Lee; Chang-Woo Lee; Kyung-Bin Song; Gyoonhee Han; Julian Simon; Hwan Mook Kim; Misun Won
Journal:  Invest New Drugs       Date:  2010-04-30       Impact factor: 3.850

4.  Differential effects of prenylation and s-acylation on type I and II ROPS membrane interaction and function.

Authors:  Nadav Sorek; Orit Gutman; Einat Bar; Mohamad Abu-Abied; Xuehui Feng; Mark P Running; Efraim Lewinsohn; Naomi Ori; Einat Sadot; Yoav I Henis; Shaul Yalovsky
Journal:  Plant Physiol       Date:  2010-12-07       Impact factor: 8.340

5.  Geranylgeranyltransferase I inhibitors target RalB to inhibit anchorage-dependent growth and induce apoptosis and RalA to inhibit anchorage-independent growth.

Authors:  Samuel C Falsetti; De-an Wang; Hairuo Peng; Dora Carrico; Adrienne D Cox; Channing J Der; Andrew D Hamilton; Saïd M Sebti
Journal:  Mol Cell Biol       Date:  2007-09-17       Impact factor: 4.272

6.  RHOB influences lung adenocarcinoma metastasis and resistance in a host-sensitive manner.

Authors:  Diego Luis-Ravelo; Iker Antón; Carolina Zandueta; Karmele Valencia; María-José Pajares; Jackeline Agorreta; Luis Montuenga; Silvestre Vicent; Ignacio I Wistuba; Javier De Las Rivas; Fernando Lecanda
Journal:  Mol Oncol       Date:  2013-11-12       Impact factor: 6.603

Review 7.  Imprinted and X-linked non-coding RNAs as potential regulators of human placental function.

Authors:  Sam Buckberry; Tina Bianco-Miotto; Claire T Roberts
Journal:  Epigenetics       Date:  2013-09-30       Impact factor: 4.528

8.  RhoB regulates the function of macrophages in the hypoxia-induced inflammatory response.

Authors:  Gaoxiang Huang; Jie Su; Mingzhuo Zhang; Yiduo Jin; Yan Wang; Peng Zhou; Jian Lu
Journal:  Cell Mol Immunol       Date:  2015-09-21       Impact factor: 11.530

9.  Efatutazone, an oral PPAR-γ agonist, in combination with paclitaxel in anaplastic thyroid cancer: results of a multicenter phase 1 trial.

Authors:  R C Smallridge; J A Copland; M S Brose; J T Wadsworth; Y Houvras; M E Menefee; K C Bible; M H Shah; A W Gramza; J P Klopper; L A Marlow; M G Heckman; R Von Roemeling
Journal:  J Clin Endocrinol Metab       Date:  2013-04-15       Impact factor: 5.958

10.  New specific molecular targets for radio-chemotherapy of rectal cancer.

Authors:  Kristin Snipstad; Christopher G Fenton; Jørn Kjaeve; Guanglin Cui; Endre Anderssen; Ruth H Paulssen
Journal:  Mol Oncol       Date:  2009-11-25       Impact factor: 6.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.